Abacus Health Products Inc (OTCMKTS:ABAHF – Get Free Report) was down 5.1% during mid-day trading on Thursday . The stock traded as low as $4.60 and last traded at $4.84. 9,300 shares were traded during mid-day trading, a decline of 9% from the average daily volume of 10,164 shares. The stock had previously closed at $5.10.
Abacus Health Products Stock Performance
The business has a 50-day moving average price of $4.84 and a 200 day moving average price of $4.84.
Abacus Health Products Company Profile
Abacus Health Products (OTCMKTS: ABAHF) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of prescription and over-the-counter (OTC) healthcare products. The company targets established therapeutic areas where existing safety and efficacy data can be leveraged to accelerate regulatory approval and market launch. By sourcing under-commercialized assets or products nearing patent expiry, Abacus aims to extend product lifecycles and deliver value to healthcare providers and consumers.
Abacus’s portfolio is built around topical and consumer-focused formulations, including treatments for dermatological conditions, pain management and common cold or flu symptoms.
Featured Stories
- Five stocks we like better than Abacus Health Products
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Abacus Health Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Health Products and related companies with MarketBeat.com's FREE daily email newsletter.
